Skip to Content

KADIAN 50 mg (Morphine Sulfate Extended Release 50 mg)

Pill with imprint KADIAN 50 mg is Blue, Capsule-shape and has been identified as Morphine Sulfate Extended Release 50 mg. It is supplied by Actavis.

Morphine is used in the treatment of chronic pain; neonatal abstinence syndrome; pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Morphine 50 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for KADIAN 50 mg

Morphine sulfate extended release 50 mg KADIAN 50 mg
Morphine sulfate extended release 50 mg KADIAN 50 mg
Morphine sulfate extended release 50 mg KADIAN 50 mg

Morphine Sulfate Extended Release

Imprint
KADIAN 50 mg
Strength
50 mg
Color
Blue
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Actavis

Labelers / Repackagers

NDC CodeLabeler / Repackager
00228-3504 Actavis Pharma, Inc.
49884-0835 Par Pharmaceutical, Inc.
52544-0052 Watson Pharmaceuticals, Inc.
54868-4572 Physicians Total Care Inc. (repackager)
35356-0050 Lake Erie Medical and Surgical Supply (repackager)
68071-0480 Nucare Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

Related Images for "KADIAN 50 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.